arrow
A

Anǵela Tincani

university of milan
H指数:103
被引数:4.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The landscape of serum autoantibodies in lupus nephritis

狼疮性肾炎患者血清自身抗体的谱系

2026-07-010
PRE
Monoclonal Antibodies in Pregnancy of Patients with Systemic Lupus Erythematosus: Friend or Foe? A Case Report of a Patient with Multiple Pregnancies

系统性红斑狼疮患者妊娠期中的单克隆抗体:益友还是祸根?——一例多次妊娠患者的病例报告

2026-04-080
OAAI
Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries

抗磷脂综合征的心血管风险因素控制,以及原发性抗磷脂综合征与系统性红斑狼疮相关抗磷脂综合征(SURF-SLE和APS项目)之间的差异:一项来自11个国家1003例个体的横断面研究

2025-11-190
PRE
Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE survey

冲突信息对妊娠及哺乳期抗风湿药物使用的影响:全球PRAISE调查中医疗提供者的观点

2025-07-160
OA
Multicenter study to improve clinical interpretation of anticardiolipin and anti-β2-glycoprotein I antibody test results for diagnosis of antiphospholipid syndrome

多中心研究以提高抗心磷脂抗体和抗β2-糖蛋白I抗体检测结果在抗磷脂综合征诊断中的临床解读

2025-05-160
PRE
Pregnancy-related issues in rare and low-prevalence diseases: results of ERN transversal working group on pregnancy and family planning survey
2025-03-100
OAAI
Prevalence and target attainment oftraditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries
2024-07-012
PRE
WHAT IS THE IMPACT OF CONFLICTING INFORMATION ON THE USE OF ANTI-RHEUMATIC DRUGS IN PREGNANCY AND BREASTFEEDING? LIKELIHOOD FOR APPREHENSION AND MEDICATION CESSATION REPORTED BY HEALTH CARE PROVIDERS IN THE GLOBAL PRAISE SURVEY

冲突信息对抗风湿药物在孕期和哺乳期使用的影响是什么?全球PRAISE调查中,卫生保健提供者报告的担忧和停药可能性。

2024-06-010
PRE
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence
2024-05-016
PRE
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases
2023-09-0114
OAAI
2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
2023-08-28139
PRE
Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group (vol 163, pg 29, 2023)
2023-07-010
PRE
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) (vol 122, pg 1612, 2022)
2023-05-240
PRE
Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group
2023-05-017
PRE